
Venture capital
Avant Bio
AVANT BIO is a New York-based investment firm focused on life sciences and healthtech companies that build technologies enabling the development of new therapeutics.
Investment activity
Round-by-round activity is part of PRO
Key signal this week
Is Avant Bio right for your round?
Key stats
Fund cycle Public record
Fund vehicles on public registers (SEC adviser filings). Values are the gross assets each filing reports, not fund sizes.
Latest investments
Rounds Avant Bio joined, from press and the firm’s own posts.
Every round Avant Bio joined
Round sizes, Avant Bio’s role and who invested alongside.
Notable portfolio
Portfolio and exits
Every company Avant Bio backed and how the exits played out.
Where the money goes
Share of companies at first investment, from the rounds we track.
Investment team
Where to meet Avant Bio
Events where Avant Bio’s team spoke or showed up, from event programmes, press and the firm’s own posts.
Signals
Register and fund filings are free. Website, team and portfolio changes we pick up are PRO.
Founders also look at
Frequently asked questions
Avant Bio is based in New York, United States.
1 fund vehicle is on public registers (SEC adviser filings), including AVANT BIO FUND II LP.
Sectors: Life sciences, Health tech, AI. From the firm’s own website.
Backs companies at the convergence of biology and advanced technology that speed up and improve therapeutic development, including tools, manufacturing, AI and healthtech. It targets overlooked high-potential companies, using insider access, and supports founders with its network, expertise and active involvement. From the firm’s own website.
Avant Bio lists 5 portfolio companies on its website: Abbelight, Intrepid Labs, Nomic Bio, PathPresenter and PL BioScience.
Firms whose websites list some of the same companies include 2048 Ventures, BVP and General Inception.
Know before Avant Bio’s next round is announced.
PRO tracks Avant Bio’s filings, hires and portfolio changes the day they land, alongside 3,869 other firms.